Lizel G Lloyd, Angela Dramowski, Adrie Bekker, Daynia Elizabeth Ballot, Cecilia Ferreyra, Birgitta Gleeson, Trusha Nana, Michael Sharland, Sithembiso Christopher Velaphi, Jeannette Wadula, Andrew Whitelaw, Mirjam Maria van Weissenbruch
{"title":"新生儿医护相关感染预测(NeoHoP)评分的多中心外部验证:一项回顾性病例对照研究。","authors":"Lizel G Lloyd, Angela Dramowski, Adrie Bekker, Daynia Elizabeth Ballot, Cecilia Ferreyra, Birgitta Gleeson, Trusha Nana, Michael Sharland, Sithembiso Christopher Velaphi, Jeannette Wadula, Andrew Whitelaw, Mirjam Maria van Weissenbruch","doi":"10.1136/bmjpo-2024-002748","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Neonatal mortality due to severe bacterial infections is a pressing global issue, especially in low-middle-income countries (LMICs) with constrained healthcare resources. This study aims to validate the Neonatal Healthcare-associated infectiOn Prediction (NeoHoP) score, designed for LMICs, across diverse neonatal populations.</p><p><strong>Methods: </strong>Prospective data from three South African neonatal units in the Neonatal Sepsis Observational (NeoOBS) study were analysed. The NeoHoP score, initially developed and validated internally in a South African hospital, was assessed using an external cohort of 573 sepsis episodes in 346 infants, focusing on different birth weight categories. Diagnostic metrics were evaluated, including sensitivity, specificity, positive predictive value and area under the receiver operating characteristic curve.</p><p><strong>Results: </strong>The external validation cohort displayed higher median birth weight and gestational age compared with the internal validation cohort. A significant proportion were born before reaching healthcare facilities, resulting in increased sepsis evaluation, and diagnosed healthcare-associated infections (HAIs). Gram-negative infections predominated, with fungal infections more common in the external validation cohort.The NeoHoP score demonstrated robust diagnostic performance, with 92% specificity, 65% sensitivity and a positive likelihood ratio of 7.73. Subgroup analysis for very low birth weight infants produced similar results. The score's generalisability across diverse neonatal populations was evident, showing comparable performance across different birth weight categories.</p><p><strong>Conclusion: </strong>This multicentre validation confirms the NeoHoP score as a reliable 'rule-in' test for HAI in neonates, regardless of birth weight. Its potential as a valuable diagnostic tool in LMIC neonatal units addresses a critical gap in neonatal care in low-resource settings.</p>","PeriodicalId":9069,"journal":{"name":"BMJ Paediatrics Open","volume":"8 1","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11448137/pdf/","citationCount":"0","resultStr":"{\"title\":\"Multicentre external validation of the Neonatal Healthcare-associated infectiOn Prediction (NeoHoP) score: a retrospective case-control study.\",\"authors\":\"Lizel G Lloyd, Angela Dramowski, Adrie Bekker, Daynia Elizabeth Ballot, Cecilia Ferreyra, Birgitta Gleeson, Trusha Nana, Michael Sharland, Sithembiso Christopher Velaphi, Jeannette Wadula, Andrew Whitelaw, Mirjam Maria van Weissenbruch\",\"doi\":\"10.1136/bmjpo-2024-002748\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Neonatal mortality due to severe bacterial infections is a pressing global issue, especially in low-middle-income countries (LMICs) with constrained healthcare resources. This study aims to validate the Neonatal Healthcare-associated infectiOn Prediction (NeoHoP) score, designed for LMICs, across diverse neonatal populations.</p><p><strong>Methods: </strong>Prospective data from three South African neonatal units in the Neonatal Sepsis Observational (NeoOBS) study were analysed. The NeoHoP score, initially developed and validated internally in a South African hospital, was assessed using an external cohort of 573 sepsis episodes in 346 infants, focusing on different birth weight categories. Diagnostic metrics were evaluated, including sensitivity, specificity, positive predictive value and area under the receiver operating characteristic curve.</p><p><strong>Results: </strong>The external validation cohort displayed higher median birth weight and gestational age compared with the internal validation cohort. A significant proportion were born before reaching healthcare facilities, resulting in increased sepsis evaluation, and diagnosed healthcare-associated infections (HAIs). Gram-negative infections predominated, with fungal infections more common in the external validation cohort.The NeoHoP score demonstrated robust diagnostic performance, with 92% specificity, 65% sensitivity and a positive likelihood ratio of 7.73. Subgroup analysis for very low birth weight infants produced similar results. The score's generalisability across diverse neonatal populations was evident, showing comparable performance across different birth weight categories.</p><p><strong>Conclusion: </strong>This multicentre validation confirms the NeoHoP score as a reliable 'rule-in' test for HAI in neonates, regardless of birth weight. Its potential as a valuable diagnostic tool in LMIC neonatal units addresses a critical gap in neonatal care in low-resource settings.</p>\",\"PeriodicalId\":9069,\"journal\":{\"name\":\"BMJ Paediatrics Open\",\"volume\":\"8 1\",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11448137/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Paediatrics Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/bmjpo-2024-002748\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PEDIATRICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Paediatrics Open","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjpo-2024-002748","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
摘要
背景和目标:严重细菌感染导致的新生儿死亡是一个紧迫的全球性问题,尤其是在医疗资源有限的中低收入国家(LMIC)。本研究旨在验证专为中低收入国家设计的新生儿医护相关感染预测(NeoHoP)评分,该评分适用于不同的新生儿群体:分析了新生儿败血症观察(NeoOBS)研究中南非三个新生儿科室的前瞻性数据。NeoHoP评分最初是在南非一家医院内部开发和验证的,并通过外部队列对346名婴儿的573例败血症病例进行了评估,重点关注不同出生体重类别的婴儿。评估的诊断指标包括灵敏度、特异性、阳性预测值和接收者操作特征曲线下面积:结果:与内部验证队列相比,外部验证队列的出生体重和胎龄中位数更高。很大一部分婴儿是在到达医疗机构之前出生的,这导致败血症评估和确诊的医疗相关感染(HAIs)增加。在外部验证队列中,革兰氏阴性感染占多数,真菌感染更为常见。NeoHoP评分显示出强大的诊断性能,特异性为92%,灵敏度为65%,阳性似然比为7.73。针对极低出生体重儿的分组分析也得出了类似的结果。该评分在不同新生儿群体中的通用性非常明显,在不同出生体重类别中表现相当:此次多中心验证证实,无论出生体重如何,NeoHoP 评分都是新生儿 HAI 的可靠 "规则 "测试。它有可能成为低收入和中等收入国家新生儿科的重要诊断工具,填补了低资源环境下新生儿护理的一个重要空白。
Multicentre external validation of the Neonatal Healthcare-associated infectiOn Prediction (NeoHoP) score: a retrospective case-control study.
Background and objectives: Neonatal mortality due to severe bacterial infections is a pressing global issue, especially in low-middle-income countries (LMICs) with constrained healthcare resources. This study aims to validate the Neonatal Healthcare-associated infectiOn Prediction (NeoHoP) score, designed for LMICs, across diverse neonatal populations.
Methods: Prospective data from three South African neonatal units in the Neonatal Sepsis Observational (NeoOBS) study were analysed. The NeoHoP score, initially developed and validated internally in a South African hospital, was assessed using an external cohort of 573 sepsis episodes in 346 infants, focusing on different birth weight categories. Diagnostic metrics were evaluated, including sensitivity, specificity, positive predictive value and area under the receiver operating characteristic curve.
Results: The external validation cohort displayed higher median birth weight and gestational age compared with the internal validation cohort. A significant proportion were born before reaching healthcare facilities, resulting in increased sepsis evaluation, and diagnosed healthcare-associated infections (HAIs). Gram-negative infections predominated, with fungal infections more common in the external validation cohort.The NeoHoP score demonstrated robust diagnostic performance, with 92% specificity, 65% sensitivity and a positive likelihood ratio of 7.73. Subgroup analysis for very low birth weight infants produced similar results. The score's generalisability across diverse neonatal populations was evident, showing comparable performance across different birth weight categories.
Conclusion: This multicentre validation confirms the NeoHoP score as a reliable 'rule-in' test for HAI in neonates, regardless of birth weight. Its potential as a valuable diagnostic tool in LMIC neonatal units addresses a critical gap in neonatal care in low-resource settings.